Abstract: The invention relates generally to methods for diagnosis and treatment of follicular lymphoma or diffuse large B cell lymphoma. Specifically, the invention relates to detecting a lysine (K)-specific methyltransferase 2D (KMT2D) alteration to diagnose or treat follicular lymphoma or diffuse large B cell lymphoma.
Type:
Application
Filed:
March 17, 2016
Publication date:
August 9, 2018
Applicants:
Memorial Sloan Ketteting Cancer Center, CORNELL UNIVERSITY
Inventors:
Hans-Guido WENDEL, Ari MELNICK, Ana ORTEGA MOLINA, Isaac BOSS